coronary atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Participate in this clinical study voluntarily and sign the informed consent voluntarily; (2) Aged 18 to 80 years male and female; (3) The subjects had PCI indications, and the stents were strung before and after the lesion; (4) The subject must be understandable and able to stick to the follow-up plan.
Exclusion criteria
Exclusion criteria: (1) Suffering from mental illness or mental disorders; Not having full capacity for civil liability; (2) Patients with malignant tumors, severe liver and kidney diseases and other diseases; (3) Participated in other clinical trials in the last 3 months; (4) Any history, as determined by the researcher may interfere with the test results or increase the risk of patients;(5) Poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of success; | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedure time of target lesion(minutes);Contrast dosage of target lesion (ml);MACE; | — |
Countries
China
Contacts
Chongqing Kanghua Zhonglian Cardiovascular Hospital